Bio E COVID-19 Vaccine in Hindi – Kya Hai Biological E Vaccine?

Biological E ek COVID-19 Vaccine hai jo punah sanyojak-protein (recombinant-protein) takaneek ka upayog karta hai jisamen koshikaon mein pratiraksha pratikriya (immune response) ko protsaahit karane ke lie ek haanirahit ajent ka upayog kiya jaata hai. Company ne Biological E COVID-19 Vaccine ko Houston mein Baylor College of Medicine aur Dynavax Technologies Corporation ke saath milkr yah vaccine vikasit kiya hai. Pichhale maheene ke ant mein ise Bharat ke drug’s regulator se teesere charan ke pareekshan karne kee manjooree milee thee. Company ne kaha ki yah desh mein sabase sastee COVID-19 teekon mein se ek hogee. Aaiye Biological E COVID-19 Vaccine ke baare me kuch aur baaton ke baare me charcha karen aur jaante hain ki yah vaccine kab tak Bharat me launch hogi.

Kab Launch Hogi Biological E COVID-19 Vaccine?

Bio E ya Biological E ke Bharat mein launch hone se COVID-19 Vaccine kee kamee ko kam karane mein madad mil sakatee hai jo vartamaan mein desh ke vaccination abhiyaan mein baadha ban rahee hai. Vartamaan mein, Bio E Vaccine ek bade vaishvik adhyayan ke hisse ke roop mein desh bhar ke 15 kendron par 18-80 varsh aayu samooh mein 1,268 svasth svayansevakon par do-khuraak teeka ke teesere charan pareekshanon (Phase III Trials) kee taiyaaree mein vyast hai.

Mahima Datla, jo Biological E kee prabandh nideshak hain, ne kaha ki Bio E sarakaaree salaah ke aadhaar par aapaatakaaleen upayog praadhikaran (EUA) ke lie laagoo hoga.Unhone kaha ki Vaccine ka utpaadan August se shuru ho jayega, aur launch ke samay se company ke pas 75-80 million vaccine ek mahine ke andr taiyaar karne ki kshamta hogi.

Mahima Datla ne kaha ki nishchit roop se company iss gambhir stithi ka faayda nahi uthayegi. Unhone yah bhi kaha ki ,“Ham is vyavasaay mein bahut pahle se hain, COVID ne hamen is vyavasaay mein pravesh nahin karaaya aur ham poorv-mahaamaaree ke samay ke teekon ko un deshon tak pahunchaane par garv karate hain, jinhen isakee sabase adhik aavashyakata thee.”

Samapan

Coronavirus Infection se joojh raha Bharat, apni kul aabadi ke keval 10% logon ko hee vaccine pradaan karwa paya hai. Isne AstraZeneca vaccine kee kul 163 million khuraaken lee hain jise Bharat mein Covaxin ke naam se jaana jata hai. Desh ko Russia se Sputnik V COVID-19 Vaccine kee khuraak bhee milee hai, haalaanki ise abhee tak desh mein launch nahin kiya gaya hai. Bharat ne Pfizir/BioNTech aur Moderna se bhee apane vaccines desh ko bechane kee appeal kee hai.

Bharat mein Bio E COVID-19 Vaccine ke launch se vartamaan me vaccine kee kamee ko kam karane mein madad mil sakatee hai jo desh ke teekaakaran abhiyaan mein baadha ban rahee hai. Vaishvik roop se, Covaxin aur Covishield ke alaava, $10 kee keemat vaale Russian Vaccine Sputnik V, ko aapaatakaaleen upayog praadhikaran (EUA) praapt hua hai, lekin Bharat ko abhi vaccine ke aayaat par hee nirbhar rahana hoga kyonki COVID-19 Vaccine ka sthaaneey vinirmaan keval July-September timaahee mein shuroo hone kee ummeed hai.